Chondropenia: current concept review

详细信息    查看全文

• 作者：A. Speziali ; M. Delcogliano ; M. Tei ; G. Placella ; M. Chillemi…
• 关键词：Chondropenia ; Early osteoarthritis ; Cartilage degeneration ; Matrix metalloproteases
• 刊名：MUSCULOSKELETAL SURGERY
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：99
• 期：3
• 页码：189-200
• 全文大小：2,029 KB
• 参考文献：1.Mandelbaum BR, Romanelli DA, Knapp TP (2000) Articular cartilage repair: assessment and classification. Oper Tech Sports Med 8(2):90-7
  2.Lorenz H, Richter W (2006) Osteoarthritis: cellular and molecular changes in degenerating cartilage. Prog Histochem Cytochem 40:135-63PubMed
  3.Aydin AT, ?zenci M, Gür S (2007) Chondropenia: early stage degenerative disease. Acta Orthop Traumatol Turc 41(Suppl 2):19-4PubMed
  4.Papalia R, Zampagna B, Torre G, Lanotte A, Vasta S, Albo E, Tecame A, Denaro V (2014) Sarcopenia and its relationship with osteoarthritis: risk factor or direct consequence? Musculoskelet Surg 98(1):9-4PubMed
  5.Lorenz H et al (2005) Early and stable upregulation of collagen II, collagen I and YLK expression levels in cartilage during early experimental osteoarthritis occurs independent of joint location and histological grading. Arthritis Res Ther 7(1):156-65
  6.McDevitt C, Gilbertson E, Muir H (1977) An experimental model of osteoarthritis; early morphological and biochemical changes. J Bone Joint Surg Br 59(1):24-5PubMed
  7.Miosge N, Hartmann M, Maelicke C, Herken R (2004) Expression of collagen type I and type II in consecutive stages of human osteoarthritis. Histochem Cell Biol 122(3):229-36PubMed
  8.Sakakibara Y, Miura T, Iwata H, Kikuchi T, Yamaguchi T, Yoshimi T et al (1994) Effect of high-molecular weight sodium hyaluronate on immobilized rabbit knee. Clin Orthop 299:282-92PubMed
  9.Wenz W, Breusch SJ, Graf J, Stratmann U (2000) Ultrastructural findings after intraarticular application of hyaluronan in a canine model of arthropathy. J Orthop Res 18(4):604-12PubMed
  10.Bluteau G, Conrozier T, Mathieu P, Vignon E, Herbage D, Mallein-Gerin F (2001) Matrix metalloproteinase-1, -3, -13 and aggrecanase-1 and -2 are differentially expressed in experimental osteoarthritis. Biochim Biophys Acta 1526(2):147-58PubMed
  11.Pelletier JP, Martel-Pelletier J, Ghandur-Mnaymneh L, Howell DS, Woessner JF Jr (1985) Role of synovial membrane inflammation in cartilage matrix breakdown in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum 28(5):554-61PubMed
  12.Brandt KD, Myers SL, Burr D, Albrecht M (1991) Osteoarthritic changes in canine articular cartilage, subchondral bone, and synovium fifty-four months after transection of the anterior cruciate ligament. Arthritis Rheum 34(12):1560-570PubMed
  13.Le Graverand MP, Eggerer J, Vignon E, Otterness IG, Barclay L, Hart DA (2002) Assessment of specific mRNA levels in cartilage regions in a lapine model of osteoarthritis. J Orthop Res 20(3):535-44PubMed
  14.Rizkalla G, Reiner A, Bogoch E, Poole AR (1992) Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest 90(6):2268-277PubMedCentral PubMed
  15.Pfander D, Rahmanzadeh R, Scheller EE (1999) Presence and distribution of collagen II, collagen I, fibronectin, and tenascin in rabbit normal and osteoarthritic cartilage. J Rheumatol 26(2):386-94PubMed
  16.Veje K, Hyllested-Winge JL, Ostergaard K (2003) Topographic and zonal distribution of tenascin in human articular cartilage from femoral heads: normal versus mild and severe osteoarthritis. Osteoarthritis Cartilage 11(3):217-27PubMed
  17.Hayami T, Funaki H, Yaoeda K, Mitui K, Yamagiwa H, Tokunaga K et al (2003) Expression of the cartilage derived anti-angiogenic factor chondromodulin-I decreases in the early stage of experimental osteoarthritis. J Rheumatol 30(10):2207-217PubMed
  18.Teshima R, Ono M, Yamashita Y, Hirakawa H, Nawata K, Morio Y (2004) Immunohistochemical collagen analysis of the most superficial layer in adult articular cartilage. J Orthop Sci 9(3):270-73PubMed
  19.Young AA, Smith MM, Smith SM, Cake MA, Ghosh P, Read RA et al (2005) Regional assessment of articular cartilage gene expression and small proteoglycan metabolism in an animal model of osteoarthritis. Arthritis Res Ther 7(4):R852–R861PubMedCentral PubMed
  20.Hambach L, Neureiter D, Zeiler G, Kirchner T, Aigner T (1998) Severe disturbance of the distribution and expression of type VI collagen chains in osteoarthritic articular cartilage. Arthritis Rheum 41(6):986-96PubMed
  21.Appleyard RC, Burkhardt D, Ghosh P, Read R, Cake M, Swain MV et al (2003) Topographical analysis of the structural, biochemical and dynamic biomechanical properties of cartilage in an ovine model of osteoarthritis. Osteoarthritis Cartilage 11(1):65-7PubMed
  22.Nerlich AG, Wiest I, von der Mark K (1993) Immunohistochemical analysis of interstitial collagens in cartilage of different stages of osteoarthritis. Virchows Arch B Cell Pathol Incl Mol Pathol 63(4):249-55PubMed
  23.Tchetina EV, Squires G (2005) Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions. J Rhe
• 作者单位：A. Speziali (1)
  M. Delcogliano (1)
  M. Tei (1)
  G. Placella (1)
  M. Chillemi (1)
  R. Tiribuzi (2)
  G. Cerulli (1) (2) (3)
  
  1. Institute of Orthopedic and Traumatology, Catholic University, ‘A. Gemelli-Hospital, Largo F. Vito1, 00168, Rome, Italy
  2. Translational Research Institute for Musculoskeletal System ‘Nicola Cerulli- LPMRI, Arezzo, Italy
  3. G.B. Pontani 9, 06128, Perugia, Italy
  
• 刊物主题：Orthopedics; Surgical Orthopedics;
• 出版者：Springer Milan
• ISSN：2035-5114

文摘

The term “chondropenia-indicates the early stage of degenerative cartilage disease, and it has been identified by carefully monitoring early-stage osteoarthritis (OA). Not only is it the loss of articular cartilage volume, but it is also a rearrangement of biomechanical, ultrastructural, biochemical and molecular properties typical of healthy cartilage tissue. Diagnosing OA at an early stage or an advanced stage is valuable in terms of clinical and therapeutic outcome. In fact degenerative phenomena are supported by a complex biochemical cascade which unbalances the extracellular matrix homeostasis, closely regulated by chondrocytes. In the first stage an intense inflammatory reaction is triggered: pro-catabolic cytokines such as IL-1β and TNF-α triggering matrix metalloproteases and aggrecanase (ADAMT-4 and 5), responsible for the early loss of ultrastructural components, such as type II collagen and aggrecan. In addition nitric oxide and reactive oxygen species modulate the physiopathology of the condral matrix inducing apoptosis of chondrocytes through a mitochondria-dependent pathway. In addition, “Lonely Death- chondrocytes, are confined within a dense, avascular extracellular matrix capsule, and can trigger a genetically induced apoptosis and necrosis. The degenerative process starts from a central point and then spreads in a centrifugal manner in depth and in adjacent areas, eventually covering the whole joint; chondropenia represents a journey from the first clinically detectable time-point until it can be characterized as frank osteoarthritis. Currently, there are no instruments sensitive enough which allow a timely diagnosis of chondropenia. Innovative magnetic resonance imaging techniques, such as T2 mapping, can be effective and a sensitive diagnostic instrument for quantifying cartilage volume and proteoglycan content. However, avant-garde biophysical techniques, such as mechanical indenters, ultrasound and biochemical markers (uCTX-II), are rational and scientific tools applicable to the clinical and therapeutic management of early degenerative cartilage disease. The objective of this review on chondropenia is to present a state of the art and innovative concepts. Keywords Chondropenia Early osteoarthritis Cartilage degeneration Matrix metalloproteases